二氯美维库铵|T22371|TargetMol

Mivacurium dichloride
106861-44-3

￥354 2mg 起订

￥567 5mg 起订

￥823 10mg 起订

上海更新日期：2024-09-30

TargetMol中国（陶术生物）

VIP3年

联系人：邵小姐

手机：4008200310 拨打

邮箱：marketing@tsbiochem.com

产品详情:

中文名称：: 二氯美维库铵

英文名称：: Mivacurium dichloride

CAS号：: 106861-44-3

品牌：: TargetMol

产地：: 美国

保存条件：: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

纯度规格：: 99.52%

产品类别：: 抑制剂

货号：: T22371

Product Introduction

Bioactivity

名称	Mivacurium dichloride
描述	Mivacurium dichloride (Mivacurium chloride) is a non-depolarising, rapid neuromuscular blocker of short duration, used therefore as anesthetic, to provide skeletal muscle relaxation in minor surgical operations, in emergency surgical procedures of short to intermediate duration and during intubation of the trachea.
体外活性	Mivacurium caused pseudo-allergic reactions in wild-type mice by inducing mast cells to release histamine.?However, it did not induce a similar phenomenon in KitW-sh/W-sh mice.?Furthermore, MrgprB2-knockout mice displayed no inflammatory response to mivacurium.?Mivacurium induced LAD2 cell degranulation in a dose-dependent manner.?Mivacurium stimulated intracellular calcium ion (Ca2+) influx in MRGPRX2-HEK293 cells but not in NC-HEK293 cells.?However, mivacurium induced the release of only low levels of mediators in LAD2 cells transfected with MRGPRX2-targeted small interfering (si)RNA.?Notably, cytokine release was not observed in LAD2 cells even when stimulated with high concentrations of mivacurium[1].
体内活性	Mivacurium is rapidly hydrolyzed in the plasma with a short duration of action(< 10 min). Mivacurium has lots of advantages, like a rapid effect, nonneurological toxicity and a lack of heart rate alteration. Mivacurium causes pseudo-allergic reactions in C57 wild-type mice by inducing mast cells to release histamine and a decrease in body temperature[1].
存储条件	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
溶解度	Ethanol : 100 mg/ml (90.9 mM) DMSO : 100 mg/ml (90.9 mM) H2O : 100 mg/ml (90.9 mM)
关键字	skeletal \| nAChR \| inhibit \| muscle \| Nicotinic acetylcholine receptors \| Inhibitor \| Mivacurium Dichloride \| Short-duration \| Mivacurium dichloride \| non-depolarizing \| neuromuscular \| relaxant \| Mivacurium \| steroidal \| Mivacurium Chloride \| benzylisoquinoline
相关产品	Pilocarpine Hydrochloride \| Levamisole hydrochloride \| Choline chloride \| Pilocarpine nitrate \| CLOZAPINE N-OXIDE \| Pempidine \| Forskolin \| (+)-Sparteine \| Propoxur \| Adiphenine hydrochloride \| Ribavirin \| Nanofin
相关库	抑制剂库 \| 经典已知活性库 \| 已知活性化合物库 \| FDA 上市药物库 \| 神经退行性疾病化合物库 \| 膜蛋白靶向化合物库 \| 疼痛相关化合物库

米库氯铵|||二氯美维库铵|||Mivacurium chloride|TargetMol

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿，致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区，已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库，以及多种类型的生化试剂产品，包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等，此外，我们还建设有CADD（计算机辅助药物设计）研究中心、药理实验室、药化合成平台三大技术中心，全方位满足客户的定制需求。凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持，我们将有效帮助您缩短研发周期，取得更成功的结果。

成立日期	(12年)
注册资本	566.265100万人民币
员工人数	100-500人
年营业额	￥ 1亿以上
经营模式	贸易,工厂,试剂,定制,服务
主营行业	天然产物,生化试剂,分子生物学,分子砌块,生物技术服务